These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 2532634
1. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170. Sasai K, Shibamoto Y, Takahashi M, Abe M, Wang J, Zhou L, Nishimoto S, Kagiya T. Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634 [Abstract] [Full Text] [Related]
2. KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics. Sasai K, Shibamoto Y, Takahashi M, Zhou L, Hori H, Nagasawa H, Shibata T, Inayama S, Abe M. Cancer Chemother Pharmacol; 1990 Nov; 26(2):112-6. PubMed ID: 2140730 [Abstract] [Full Text] [Related]
3. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170). Murayama C, Suzuki A, Suzuki T, Miyata Y, Sakaguchi M, Tanabe Y, Tanaka N, Mori T. Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527 [Abstract] [Full Text] [Related]
4. In vivo radiosensitizing effect of nitroimidazole derivative KIN-804. Tada T, Nakajima T, Onoyama Y, Murayama C, Mori T, Nagasawa H, Hori H, Inayama S. Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):601-5. PubMed ID: 8005823 [Abstract] [Full Text] [Related]
5. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration. Murayama C, Suzuki A, Sato C, Tanabe Y, Miyata Y, Shoji T, Suzuki T, Sakaguchi M, Mori T. Int J Radiat Oncol Biol Phys; 1992 Jun 15; 22(3):557-60. PubMed ID: 1531214 [Abstract] [Full Text] [Related]
6. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer. Sasai K, Nishimoto S, Shimokawa K, Hisanaga Y, Kitakabu Y, Shibamoto Y, Zhou L, Wang J, Takahashi M, Kagiya T. Int J Radiat Oncol Biol Phys; 1991 Jun 15; 20(6):1249-54. PubMed ID: 1828462 [Abstract] [Full Text] [Related]
7. Radiosensitizing activity and pharmacokinetics of multiple dose administered KU-2285 in peripheral nerve tissue in mice. Iwai H, Matsuno E, Sasai K, Shibamoto Y, Abe M. Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):591-4. PubMed ID: 8005821 [Abstract] [Full Text] [Related]
8. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity. Oya N, Shibamoto Y, Sasai K, Shibata T, Murata R, Takagi T, Iwai H, Suzuki T, Abe M. Int J Radiat Oncol Biol Phys; 1995 Aug 30; 33(1):119-27. PubMed ID: 7642409 [Abstract] [Full Text] [Related]
9. Azomycin riboside: a new radiosensitizer. Pedersen JE, Barron G, Chapman JD. Int J Radiat Oncol Biol Phys; 1982 Aug 30; 8(3-4):415-8. PubMed ID: 7107360 [Abstract] [Full Text] [Related]
10. [Recent advances in hypoxic cell radiosensitizer]. Ono K, Takahashi M, Nishidai T, Shibamoto Y, Abe M. Gan No Rinsho; 1983 Oct 30; 29(13):1608-12. PubMed ID: 6230470 [Abstract] [Full Text] [Related]
11. [Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors]. Tada T, Nakajima T, Onoyama Y, Nagasawa H, Hori H, Inayama S. Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May 25; 52(5):688-90. PubMed ID: 1508643 [Abstract] [Full Text] [Related]
12. KIH-802: 2-nitroimidazole-1-acetohydroxamate as a hypoxic cell radiosensitizer. Hori H, Murayama C, Mori T, Shibamoto Y, Abe M, Onoyama Y, Inayama S. Int J Radiat Oncol Biol Phys; 1989 Apr 25; 16(4):1029-32. PubMed ID: 2703381 [Abstract] [Full Text] [Related]
13. [Radiosensitizing effects of nitroimidazole derivative, KIN-804]. Tada T. Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jan 25; 55(1):70-5. PubMed ID: 7899069 [Abstract] [Full Text] [Related]
14. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole. Brown DM, Dionet C, Brown JM. Radiat Res; 1984 Jan 25; 97(1):162-70. PubMed ID: 6229806 [Abstract] [Full Text] [Related]
15. Clinical trials of radiosensitizers: what should we expect? Brown JM. Int J Radiat Oncol Biol Phys; 1984 Mar 25; 10(3):425-9. PubMed ID: 6231272 [Abstract] [Full Text] [Related]
16. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343). Murayama C, Suzuki A, Sato C, Tanabe Y, Shoji T, Miyata Y, Nishio A, Suzuki T, Sakaguchi M, Mori T. Int J Radiat Oncol Biol Phys; 1993 Jun 15; 26(3):433-43. PubMed ID: 8514541 [Abstract] [Full Text] [Related]
17. [Radiosensitization by hypoxic cell radiosensitizer--present status of radiosensitizer]. Murayama C, Mori T. Gan No Rinsho; 1990 Oct 15; 36(13):2249-54. PubMed ID: 2147449 [Abstract] [Full Text] [Related]
18. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors. Ono K, Takahashi M, Nishidai T, Dodo Y, Shibamoto Y, Hiraoka M, Yukawa Y, Abe M. Radiat Med; 1984 Oct 15; 2(1):71-5. PubMed ID: 6242712 [Abstract] [Full Text] [Related]
19. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II). Herman TS, Teicher BA, Pfeffer MR, Khandekar V, Chapnick RM, Kalick GS, Rabow A. Radiat Res; 1990 Oct 15; 124(1):28-33. PubMed ID: 2146699 [Abstract] [Full Text] [Related]